Efficacyand Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis: The Phase 3 ECZTRA 6 Randomized Clinical Trial (vol 159, pg 596, 2023)

被引：0
|
作者：
Shin, L.
Kole, L. C. S.
Peebles, J. K.
机构：
来源：
JAMA DERMATOLOGY | 2023年 / 159卷 / 06期
关键词：
D O I：
10.1001/jamadermatol.2023.1955
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：673 / 673
页数：1
相关论文
共 50 条
  • [41] Dupilumab in adolescents with moderate-to-severe atopic dermatitis and a history of allergic rhinitis: Subgroup analysis from a randomized phase 3 trial
    Sher, L.
    Siegfried, E. C.
    Paller, A. S.
    Soong, W.
    Blauvelt, A.
    Hultsch, T.
    Mina-Osorio, P.
    Prescilla, R.
    Chen, Z.
    Bansal, A.
    [J]. ALLERGY, 2019, 74 : 582 - 582
  • [42] Early changes in patient-relevant endpoints in three tralokinumab pivotal phase III trials (ECZTRA 1-3) in adult patients with moderate-to-severe atopic dermatitis
    Silverberg, J. I.
    Cork, M.
    Wollenberg, A.
    Katoh, N.
    Steffensen, L. A.
    Kurbasic, A.
    Olsen, C. K.
    Kuznetsova, A.
    Osterdal, M. L.
    Vilsboll, A. W.
    Deleuran, M.
    Simpson, E.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (03) : E64 - E64
  • [43] Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program (vol 22, pg 693, 2021)
    Simpson, Eric L.
    Silverberg, Jonathan I.
    Nosbaum, Audrey
    Winthrop, Kevin L.
    Guttman-Yassky, Emma
    Hoffmeister, Karin M.
    Egeberg, Alexander
    Valdez, Hernan
    Zhang, Min
    Farooqui, Saleem A.
    Romero, William
    Thorpe, Andrew J.
    Rojo, Ricardo
    Johnson, Susan
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (06) : 905 - 905
  • [44] Integrated safety analysis of abrocitinib for the treatment of moderate-to-severe atopic dermatitis (AD) from the phase 2 and phase 3 clinical trial program
    Simpson, Eric L.
    Silverberg, Jonathan I.
    Nosbaum, Audrey
    Winthrop, Kevin
    Guttman-Yassky, Emma
    Hoffmeister, Karin M.
    Zhang, Min
    Farooqui, Saleem A.
    Johnson, Susan
    Thorpe, Andrew
    Rojo, Ricardo
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB150 - AB150
  • [45] Patient-reported outcomes with abrocitinib treatment in patients with moderate to severe atopic dermatitis: Results from a randomized, phase 3 clinical trial
    Silverberg, Jonathan I.
    Cohen, Arnon D.
    Stander, Sonja
    Feeney, Claire
    Valdez, Hernan
    Biswas, Pinaki
    Cameron, Michael C.
    DiBonaventura, Marco
    Gerber, Robert A.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB35 - AB35
  • [46] The effect of dupilumab on biomarkers in a randomized phase 2b clinical trial in adults with moderate-to-severe atopic dermatitis
    Hamilton, J.
    Hamon, S.
    Simpson, E.
    Chaudhry, U.
    Swanson, B.
    Zhang, R.
    Graham, N.
    Pirozzi, G.
    Ardeleanu, M.
    Rizova, E.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (09) : S224 - S224
  • [47] Dupilumab in Adolescents With Moderate-to-Severe Atopic Dermatitis and a History of Allergic Rhinitis: Subgroup Analysis From a Phase 3 Trial
    Sher, Lawrence
    Soong, Weily
    Mina-Osorio, Paola
    Prescilla, Randy
    Chen, Zhen
    Bansal, Ashish
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB191 - AB191
  • [48] Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial
    Blauvelt, Andrew
    Silverberg, Jonathan, I
    Lynde, Charles W.
    Bieber, Thomas
    Eisman, Samantha
    Zdybski, Jacek
    Gubelin, Walter
    Simpson, Eric L.
    Valenzuela, Fernando
    Criado, Paulo Ricardo
    Lebwohl, Mark G.
    Feeney, Claire
    Khan, Tahira
    Biswas, Pinaki
    DiBonaventura, Marco
    Valdez, Hernan
    Cameron, Michael C.
    Rojo, Ricardo
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (01) : 104 - 112
  • [49] Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program
    Simpson, Eric L.
    Silverberg, Jonathan I.
    Nosbaum, Audrey
    Winthrop, Kevin L.
    Guttman-Yassky, Emma
    Hoffmeister, Karin M.
    Egeberg, Alexander
    Valdez, Hernan
    Zhang, Min
    Farooqui, Saleem A.
    Romero, William
    Thorpe, Andrew J.
    Rojo, Ricardo
    Johnson, Susan
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (05) : 693 - 707
  • [50] Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program
    Eric L. Simpson
    Jonathan I. Silverberg
    Audrey Nosbaum
    Kevin L. Winthrop
    Emma Guttman-Yassky
    Karin M. Hoffmeister
    Alexander Egeberg
    Hernan Valdez
    Min Zhang
    Saleem A. Farooqui
    William Romero
    Andrew J. Thorpe
    Ricardo Rojo
    Susan Johnson
    [J]. American Journal of Clinical Dermatology, 2021, 22 : 693 - 707
12345